Celebrating the 2nd Annual Meeting of the Association of Parents with Epileptic Children, the author wishes to express his deep respect and admiration for the success accomplished by the Association and the enthusiasm the members showed for the past two years.
Mainly from the standpoint of a child neurologist, the author reviewed several noticeable strides of recent years which were directed toward better medical care and understanding of childhood epilepsies, dividing into three aspects (1) the growth and development of epilepsy-oriented medical perosonnels and organisations all over Japan, (2) several substantial advances in medical knowledge, especially in therapeutic measures of epilepsies, and (3) the social security and welfare for epileptic child.
Topics selected in the section (2) were as follows.
(A) On the practical implication of the obser-vation that the serum concentration of antico-nvulsants is often low in out-patient than that in in-patient.
(B) Diphenylhydantoin may be administered only once daily without significant diurnal fluc-tuation of serum concentration. However, we must be more cautious when young infants are concerned because the metabolic rate is far faster in infants in comparison to that in the elder.
(C) Development of new promising anticonvulsants ; a) sodium dipropylacetate (Depakene), b) clonazepam, and c) taurine, though still experimental.
(D) Development of new style of diet therapy ; mid-chain triglyceride regimen.
(E) exploration of seizure control by cerebellar cortical stimulation.
View full abstract